Active	Status	Sponsor type	Region	Phase	Filter
102 Active 26 Inactive 128 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

102 Trials

Active Trials   

«12

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gurses, Serdar
KEYNOTE-C16, NCT04374877: Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors	Recruiting	1	260	US, RoW	CHS-388, Casdozokitug, Pembrolizumab, Keytruda®, Toripalimab, Loqtorzi®	Coherus Biosciences, Inc., Merck Sharp & Dohme LLC	Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma, Non-small Cell Lung Cancer	12/25	08/26
STARLING, NCT05576077: A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors	Recruiting	1	60	Canada, US	TBio-4101, TIL, autologous, tumor-reactive, T-cell product, Pembrolizumab, Keytruda	Turnstone Biologics, Corp.	Breast Cancer, Colorectal Cancer, Uveal Melanoma, Cutaneous Melanoma, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma	12/24	06/25

 

«12